SAN

89.31

-0.28%↓

SHL.DE

48.15

-1.23%↓

ARGX

486.7

+0.43%↑

FRE

42.15

-0.24%↓

ONC.US

219.73

-1.77%↓

SAN

89.31

-0.28%↓

SHL.DE

48.15

-1.23%↓

ARGX

486.7

+0.43%↑

FRE

42.15

-0.24%↓

ONC.US

219.73

-1.77%↓

SAN

89.31

-0.28%↓

SHL.DE

48.15

-1.23%↓

ARGX

486.7

+0.43%↑

FRE

42.15

-0.24%↓

ONC.US

219.73

-1.77%↓

SAN

89.31

-0.28%↓

SHL.DE

48.15

-1.23%↓

ARGX

486.7

+0.43%↑

FRE

42.15

-0.24%↓

ONC.US

219.73

-1.77%↓

SAN

89.31

-0.28%↓

SHL.DE

48.15

-1.23%↓

ARGX

486.7

+0.43%↑

FRE

42.15

-0.24%↓

ONC.US

219.73

-1.77%↓

Search

Vetoquinol SA

Închisă

SectorSănătate

72.4 -0.28

Rezumat

Modificarea prețului

24h

Curent

Minim

70.8

Maxim

74.1

Indicatori cheie

By Trading Economics

Venit

11M

35M

Vânzări

10M

275M

P/E

Medie Sector

14.639

56.602

Randament dividend

1.22

Marjă de profit

12.694

EBITDA

15M

60M

Recomandări

By TipRanks

Recomandări

Cumpărare

Prognoză pe 12 luni

+64.61% upside

Dividende

By Dow Jones

Randament dividend

Medie Sector

1.22%

2.45%

Statistici piață

By TradingEconomics

Capitalizare de piață

-41M

878M

Deschiderea anterioară

72.68

Închiderea anterioară

72.4

Sentimentul știrilor

By Acuity

50%

50%

187 / 382 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Bearish Evidence

Vetoquinol SA Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

14 mai 2025, 23:40 UTC

Acțiuni populare

Stocks to Watch: UnitedHealth Group, Foot Locker, CoreWeave

14 mai 2025, 23:33 UTC

Principalele dinamici ale pieței

UnitedHealth Group Shares Fall After WSJ Reports of Investigation for Possible Medicare Fraud

14 mai 2025, 23:25 UTC

Principalele dinamici ale pieței

Biohaven Shares Down as FDA Extends PDUFA Data for Troriluzole

14 mai 2025, 23:25 UTC

Câștiguri

Xero Lifts Fiscal Year Profit 30% on Higher Prices, Subscriber Growth -- Update

14 mai 2025, 22:58 UTC

Câștiguri

Xero Lifts Fiscal Year Profit 30% on Higher Prices, Subscriber Growth

14 mai 2025, 21:35 UTC

Câștiguri

Cisco Systems Names Patterson as CFO, Patel as President

14 mai 2025, 23:59 UTC

Market Talk

Implications of Xero's Cost Outlook Aren't Clear -- Market Talk

14 mai 2025, 23:49 UTC

Market Talk

Xero's Cost Outlook Likely to Prompt Downgrades -- Market Talk

14 mai 2025, 23:48 UTC

Market Talk

Global Equities Roundup: Market Talk

14 mai 2025, 23:48 UTC

Market Talk

Nikkei May Decline on Profit-Taking After Recent Gains -- Market Talk

14 mai 2025, 23:47 UTC

Market Talk

Gold Gains on Possible Technical Recovery -- Market Talk

14 mai 2025, 23:34 UTC

Achiziții, Fuziuni, Preluări

Agnico-Eagle Mines to Subscribe for 30M Voting Common Shares of Foran Mining in Non-Brokered Private Placement at C$3 a Share

14 mai 2025, 23:10 UTC

Câștiguri

Xero Lifts FY Profit 30% on Higher Prices, Subscriber Growth -- Update

14 mai 2025, 23:07 UTC

Câștiguri

CoreWeave Posts Strong Revenue and Wins Google as a Customer. Stock Still Dives on Outlook. -- Barrons.com

14 mai 2025, 23:00 UTC

Top știri

UnitedHealth Group Is Under Criminal Investigation for Possible Medicare Fraud -- WSJ

14 mai 2025, 22:43 UTC

Câștiguri

Xero Lifts FY Profit 30% on Higher Prices, Subscriber Growth

14 mai 2025, 22:34 UTC

Câștiguri

Xero Expects 1H Operating Expense Ratio to Be Higher Than 2H>XRO.AU

14 mai 2025, 22:33 UTC

Câștiguri

Xero Expects FY26 Operating Expense Ratio of 71.5%>XRO.AU

14 mai 2025, 22:30 UTC

Câștiguri

Xero Did Not Declare a Dividend>XRO.AU

14 mai 2025, 22:30 UTC

Câștiguri

Xero FY Operating Expenses 71.8% of Operating Revenue Vs. 73.3%>XRO.AU

14 mai 2025, 22:30 UTC

Câștiguri

Xero FY Free Cashflow Margin 24.1% Vs. 20.0%>XRO.AU

14 mai 2025, 22:30 UTC

Câștiguri

Xero FY Free Cashflow NZD506.7M Vs. NZD342.1M>XRO.AU

14 mai 2025, 22:28 UTC

Câștiguri

Xero FY Ebitda NZD638.5M Vs. NZD497.4M>XRO.AU

14 mai 2025, 22:28 UTC

Câștiguri

Xero FY Adjusted Ebitda NZD640.6M Vs. NZD526.5M>XRO.AU

14 mai 2025, 22:27 UTC

Câștiguri

Xero FY Rev NZD2.10B Vs. NZD1.71B >XRO.AU

14 mai 2025, 22:27 UTC

Câștiguri

Xero FY Net NZD227.8M Vs. Net NZD174.6M >XRO.AU

14 mai 2025, 22:23 UTC

Top știri

Boeing, GE Aerospace Get Qatar Airways Order After Saudi AI Tech Deals -- 2nd Update

14 mai 2025, 22:15 UTC

Câștiguri

Correction to Cisco Earnings Article -- WSJ

14 mai 2025, 21:48 UTC

Câștiguri

CoreWeave Posts Strong Revenue but Stock Dives on Updated Outlook -- Barrons.com

14 mai 2025, 21:37 UTC

Câștiguri

Cisco Reports Solid Earnings. The Stock Is Rising. -- Barrons.com

Comparație

Modificare preț

Vetoquinol SA Așteptări

Obiectiv de preț

By TipRanks

64.61% sus

Prognoză pe 12 luni

Medie 120 EUR  64.61%

Maxim 120 EUR

Minim 120 EUR

În baza a 1 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruVetoquinol SA - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

1 ratings

1

Cumpărare

0

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

72.6 / 75.1Suport & Rezistență

Termen scurt

Bearish Evidence

Termen mediu

Bearish Evidence

Termen lung

Bearish Evidence

Sentiment

By Acuity

187 / 382 Clasament în Sănătate

Sentimentul știrilor

Neutral

Volatilitate

Sub medie

Volumul știrilor (RCV)

Peste medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Vetoquinol SA

Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region. It provides products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; infectious diseases; reproduction; behavior management; internal medicine; and cardiology-nephrology for cattle, sheep, pigs, poultry, dogs, cats, and horses. The company was founded in 1933 and is headquartered in Lure, France. Vetoquinol SA is a subsidiary of Soparfin SCA.